Literature DB >> 33123976

Cytochrome P450 oxidoreductase deficiency caused by a novel mutation in the POR gene in two siblings: case report and literature review.

Edip Unal1, Meliha Demiral2, Ruken Yıldırım3, Funda Feryal Taş2, Serdar Ceylaner4, Mehmet Nuri Özbek2.   

Abstract

INTRODUCTION: P450 oxidoreductase (POR) deficiency is a rare form of congenital adrenal hyperplasia. In both genders, it can lead to ambiguous genitalia, impaired steroidogenesis, and skeletal findings similar to those of Antley-Bixler syndrome. CASES: We describe two cases of POR deficiency. The first case was an 8.5-year-old girl who was admitted to our clinic due to ambiguous genitalia. Karyotype was 46, XX. There were mild dysmorphic facial findings and mild metacarpophalangeal joint deformity. The patient's basal cortisol and ACTH levels were normal, while 17-hydroxyprogesterone (17OHP) levels were high. Peak cortisol response to the ACTH stimulation test was found to be insufficient. Our second case, a sibling of the first case, was admitted for routine checkup at the age of 15 months. As in our first case, there were dysmorphic facial findings and metacarpophalangeal joint deformity. The genital structure was normal. Karyotype was 46, XY. Basal cortisol and ACTH levels were normal, while 17OHP level was slightly high. Peak cortisol response to the ACTH stimulation test was found to be insufficient. Based on our findings, POR deficiency was considered in both of these cases and NM_000941.3:c.929_937delTCTCGGACT(p.Ile310_Ser313delinsThr) (homozygous) mutation was detected in the POR gene that had not previously been described.
CONCLUSION: We detected a novel variant in the POR gene in two sibling cases with adrenal insufficiency, dysmorphic face, and mild skeletal findings. While the detected mutation caused ambiguous genitalia in the female case, it did not cause ambiguous genitalia in the male case.

Entities:  

Keywords:  Adrenal insufficiency; Congenital adrenal hyperplasia; Disorders of sexual development; POR deficiency; Skeletal malformation

Mesh:

Substances:

Year:  2020        PMID: 33123976     DOI: 10.1007/s42000-020-00249-z

Source DB:  PubMed          Journal:  Hormones (Athens)        ISSN: 1109-3099            Impact factor:   2.885


  4 in total

1.  Clinical, genetic, and enzymatic characterization of P450 oxidoreductase deficiency in four patients.

Authors:  Taninee Sahakitrungruang; Ningwu Huang; Meng Kian Tee; Vishal Agrawal; William E Russell; Patricia Crock; Nuala Murphy; Claude J Migeon; Walter L Miller
Journal:  J Clin Endocrinol Metab       Date:  2009-10-16       Impact factor: 5.958

2.  P450 Oxidoreductase deficiency: Analysis of mutations and polymorphisms.

Authors:  Fabian Z Burkhard; Shaheena Parween; Sameer S Udhane; Christa E Flück; Amit V Pandey
Journal:  J Steroid Biochem Mol Biol       Date:  2016-04-08       Impact factor: 4.292

3.  Cytochrome P450 oxidoreductase deficiency: identification and characterization of biallelic mutations and genotype-phenotype correlations in 35 Japanese patients.

Authors:  Maki Fukami; Gen Nishimura; Keiko Homma; Toshiro Nagai; Keiichi Hanaki; Ayumi Uematsu; Tomohiro Ishii; Chikahiko Numakura; Hirotake Sawada; Mariko Nakacho; Takanori Kowase; Katsuaki Motomura; Hidenori Haruna; Mihoko Nakamura; Akira Ohishi; Masanori Adachi; Toshihiro Tajima; Yukihiro Hasegawa; Tomonobu Hasegawa; Reiko Horikawa; Kenji Fujieda; Tsutomu Ogata
Journal:  J Clin Endocrinol Metab       Date:  2009-03-03       Impact factor: 5.958

Review 4.  Cytochrome P450 oxidoreductase deficiency caused by R457H mutation in POR gene in Chinese: case report and literature review.

Authors:  Yang Bai; Jinhui Li; Xiaoli Wang
Journal:  J Ovarian Res       Date:  2017-03-14       Impact factor: 4.234

  4 in total
  2 in total

1.  Therapeutic liver repopulation by transient acetaminophen selection of gene-modified hepatocytes.

Authors:  Anne Vonada; Amita Tiyaboonchai; Sean Nygaard; Jeffrey Posey; Alexander Mack Peters; Shelley R Winn; Alessio Cantore; Luigi Naldini; Cary O Harding; Markus Grompe
Journal:  Sci Transl Med       Date:  2021-06-09       Impact factor: 19.319

2.  In Silico Analysis of PORD Mutations on the 3D Structure of P450 Oxidoreductase.

Authors:  Muhammad Nurhafizuddin; Aziemah Azizi; Long Chiau Ming; Naeem Shafqat
Journal:  Molecules       Date:  2022-07-21       Impact factor: 4.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.